Genmab | GEN - Debt


Genmab reported DKK5.35B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Agios Pharmaceuticals USD 35.74M 4.46M Mar/2026
Almirall EUR 342.86M 61.94M Dec/2025
Amarin USD 0 0 Mar/2025
Amgen USD 57.3B 19M Jun/2026
argenx SE USD 47M 160K Jun/2026
AstraZeneca USD 32.24B 1.68B Jun/2026
Bayer EUR 36.45B 2.93B Dec/2025
BioMarin Pharmaceutical USD 4.2B 2.76B Jun/2026
Demant DKK 20.28B 706M Jun/2026
Exelixis USD 162.2M 3.73M Sep/2026
Fresenius Medical Care EUR 10.96B 66.06M Jun/2026
Genmab DKK 5.35B 5.2B Mar/2026
GlaxoSmithKline GBP 18.24B 818M Jun/2026
GN Store Nord DKK 9.96B 855M Mar/2026
GRIFOLS EUR 8.52B 1.15B Jun/2026
Hikma Pharmaceutical USD 1.6B 46M Dec/2025
Insmed USD 544.86M 180.93M Sep/2026
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 12.04B 86M Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Regeneron Pharmaceuticals USD 2.71B 400K Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
UCB EUR 3.03B 12M Dec/2024